Noveris Health Sciences (FRA:0NF1) Cyclically Adjusted Book per Share: €217.47 (As of Mar. 2026)


FRA:0NF1 Noveris Health Sciences Inc FRA:0NF1
22 GF Score
Price €1.01
View Full Analysis

What is Noveris Health Sciences Cyclically Adjusted Book per Share?

Noveris Health Sciences FRA:0NF1 -0.98% 22 Cyclically Adjusted Book per Share is €217.47 as of Mar. 2026. GuruFocus rates FRA:0NF1 with a GF Score™ of 22/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Noveris Health Sciences's adjusted book value per share for the three months ended in Mar. 2026 was €-0.024. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €217.47 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Noveris Health Sciences's average Cyclically Adjusted Book Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-13), Noveris Health Sciences's current stock price is €1.01. Noveris Health Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €217.47. Noveris Health Sciences's Cyclically Adjusted PB Ratio of today is 0.00.


Noveris Health Sciences  (FRA:0NF1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Noveris Health Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.01/217.47
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Noveris Health Sciences Cyclically Adjusted Book per Share Related Terms


Noveris Health Sciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Noveris Health Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noveris Health Sciences Cyclically Adjusted Book per Share Chart

Noveris Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 326.18 113.97 148.97

Noveris Health Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 180.09 83.19 77.59 148.97 217.47

FRA:0NF1 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Noveris Health Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noveris Health Sciences Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Noveris Health Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Noveris Health Sciences's Cyclically Adjusted PB Ratio falls into.


FRA:0NF1
22GF Score
Noveris Health Sciences Inc FRA:0NF1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noveris Health Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Noveris Health Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.024/132.2623*132.2623
=-0.024

Current CPI (Mar. 2026) = 132.2623.

Noveris Health Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 -280.000 102.002 -363.067
201609 -396.000 101.765 -514.677
201612 942.000 101.449 1,228.122
201703 984.000 102.634 1,268.064
201706 750.000 103.029 962.807
201709 767.000 103.345 981.620
201712 415.000 103.345 531.124
201803 861.000 105.004 1,084.510
201806 -289.500 105.557 -362.742
201809 788.667 105.636 987.456
201812 15.333 105.399 19.241
201903 949.333 106.979 1,173.695
201906 774.200 107.690 950.851
201909 1,234.385 107.611 1,517.151
201912 96.077 107.769 117.913
202003 493.769 107.927 605.102
202006 172.259 108.401 210.176
202009 98.292 108.164 120.191
202012 32.183 108.559 39.210
202103 138.362 110.298 165.915
202106 114.579 111.720 135.647
202109 0.000 112.905 0.000
202112 1.404 113.774 1.632
202203 -24.850 117.646 -27.937
202206 -8.271 120.806 -9.055
202209 -13.798 120.648 -15.126
202212 -2.993 120.964 -3.273
202303 -12.756 122.702 -13.750
202306 -11.930 124.203 -12.704
202309 -4.993 125.230 -5.273
202312 -7.749 125.072 -8.194
202403 -7.503 126.258 -7.860
202406 -8.483 127.522 -8.798
202409 -9.395 127.285 -9.762
202412 -8.295 127.364 -8.614
202503 -7.941 129.181 -8.130
202506 -7.868 129.892 -8.012
202509 -7.560 130.287 -7.675
202512 -6.251 130.366 -6.342
202603 -0.024 132.262 -0.024

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €217.47 mean?
Noveris Health Sciences (FRA:0NF1) has a Cyclically Adjusted Book per Share of €217.47 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Noveris Health Sciences and its competitors.
Is Noveris Health Sciences' Cyclically Adjusted Book per Share too high?
Noveris Health Sciences' current Cyclically Adjusted Book per Share is €217.47. Overall, Noveris Health Sciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Noveris Health Sciences' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Noveris Health Sciences' Cyclically Adjusted Book per Share of €217.47 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Noveris Health Sciences and its competitors. Noveris Health Sciences's current Cyclically Adjusted Book per Share is €217.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noveris Health Sciences stock overvalued right now?
Noveris Health Sciences (FRA:0NF1) has a current Cyclically Adjusted Book per Share of €217.47. The current Cyclically Adjusted Book per Share is €217.47. Noveris Health Sciences' overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Noveris Health Sciences (FRA:0NF1), the current Cyclically Adjusted Book per Share is €217.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Noveris Health Sciences Business Description

Other Exchanges MYCOF:USANVRS:Canada
Address 1890 - 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Noveris Health Sciences Inc is a biotech and life sciences company dedicated to developing and commercializing solutions for treating mental health problems and enhancing vitality. The company has a portfolio of patents it is seeking to commercialize, and is exploring opportunities in the stem cell industry. It is developing the next generation of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD).
22GF Score

Get the complete analysis for FRA:0NF1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.01
Price